logo

Orchard Therapeutics Plc (ORTX)



Trade ORTX now with
  Date
  Headline
6/5/2019 9:59:23 PM Orchard Therapeutics Announces Pricing Of Public Offering Of 9 Mln ADSs For Total Gross Proceeds Of $128 Mln
3/22/2019 9:41:13 AM Wedbush Is Raising Orchard Therapeutics plc (ORTX) FY19 Estimate To -1.89 From -2.21
3/22/2019 9:40:59 AM Wedbush Is Increasing Orchard Therapeutics plc (ORTX) Q4 19 Estimate To -0.51 From -0.55
3/22/2019 9:40:49 AM Wedbush Is Increasing Orchard Therapeutics plc (ORTX) Q3 19 Estimate To -0.50 From -0.58
3/22/2019 9:40:36 AM Wedbush Is Raising Orchard Therapeutics plc (ORTX) Q2 19 Estimate To -0.46 From -0.56
3/22/2019 9:40:23 AM Wedbush Is Increasing Orchard Therapeutics plc (ORTX) Q1 19 Estimate To -0.42 From -0.53
3/22/2019 9:39:58 AM Wedbush Reiterates Orchard Therapeutics plc (ORTX) At Outperform With $25 Price Target
3/21/2019 7:16:57 AM Orchard Therapeutics FY Net Loss Attributable To Ordinary Shareholders $230.5 Mln Vs Loss $39.7 Mln Last Year
3/18/2019 7:07:50 AM Orchard Therapeutics Appoints Ran Zheng Chief Technical Officer
3/11/2019 7:16:03 AM Orchard Therapeutics Announces Acceptance Of OTL-200 Abstract For MLD At EBMT
2/6/2019 7:35:22 AM Orchard Therapeutics Announces Acceptance Of Late-Breaking Abstracts Of OTL-101 For ADA-SCID And OTL-102 For X-CGD
12/14/2018 7:31:16 AM Orchard Therapeutics And SIRION Announce Licensing Agreement To Enhance Gene Therapy Manufacturing Efficiency
12/7/2018 7:31:34 AM Orchard Therapeutics Appointms Alicia Secor To Its Board
11/26/2018 6:25:14 AM Wedbush Starts Orchard Therapeutics plc (ORTX) At Outperform With $25 Price Target